Day: March 1, 2021

Allentown, March 01, 2021 (GLOBE NEWSWIRE) — CrossAmerica Partners LP Reports Fourth Quarter and Year-End 2020 ResultsReported Fourth Quarter 2020 Operating Income of $8.1 million and Net Income of $9.0 million compared to Operating Income of $9.4 million and Net Income of $4.3 million for the Fourth Quarter 2019Generated Fourth Quarter 2020 Adjusted EBITDA of $24.4 million and Distributable Cash Flow of $26.2 million compared to Fourth Quarter 2019 Adjusted EBITDA of $25.6 million and Distributable Cash Flow of $18.8 millionReported Fourth Quarter 2020 Gross Profit for the Wholesale Segment of $36.8 million compared to $32.7 million of Gross Profit for the Fourth Quarter 2019Reported Fourth Quarter 2020 Gross Profit for the Retail Segment of $19.5 million compared to $2.3 million of Gross Profit for the Fourth Quarter 2019Distributed...

GAITHERSBURG, Md., March 01, 2021 (GLOBE NEWSWIRE) — Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for patients suffering from autoimmune and severe inflammatory diseases, today reported financial results and provided program and business highlights for the fourth quarter and full year ended December 31, 2020.“2020 was a year of great progress for Viela, despite the many external challenges resulting from the COVID-19 global pandemic,” said Bing Yao, Ph.D., Chief Executive Officer at Viela Bio. “Most significantly, we received FDA approval for UPLIZNA® to treat adult patients with AQP4+ NMOSD and achieved solid product uptake, closed a successful public offering and continued to advance our full pipeline with the initiation of several clinical trials,...

CAMBRIDGE, Mass., March 01, 2021 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced that the Company will be participating in the Cowen 41st Annual Health Care Conference, which will take place virtually on March 1-4, 2021. Robert Ang, MBBS, MBA, Vor’s President and Chief Executive Officer, and Nathan Jorgensen, PhD, Chief Financial Officer, are scheduled to present on Thursday, March 4, 2021, at 1:30 p.m. E.T.About Vor BiopharmaVor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of...

Press Release – Paris, March 1st, 2021Danone’s Board of Directors confirms unanimous support for Emmanuel Faber,who proposes the separation of Chairman and CEO rolesFollowing a meeting on March 1st, Danone’s Board of Directors reviewed the company’s corporate governance and decided, on a proposal from Emmanuel Faber, to separate the functions of Chairman and CEO in the near future. The separation will be effective upon the appointment of a new CEO. The process to recruit a new CEO has been launched and once complete, Emmanuel Faber will focus on his role as non-executive Chairman.In the meantime, Emmanuel Faber will continue as Chairman and CEO, with the full confidence and unanimous support of the Board to exercise full operational responsibility for the company, and to lead the implementation of the adaptation plan Local...

Communiqué de presse – Paris, le 1er mars 2021Le Conseil d’administration de Danone renouvelleson soutien unanime à Emmanuel Faber, qui propose au Conseil d’initierle processus de dissociation des fonctionsRéuni le 1er mars, le Conseil d’administration de Danone a réexaminé le mode de gouvernance de l’entreprise et a décidé, sur proposition d’Emmanuel Faber, de dissocier prochainement les fonctions de Présidence et de Direction générale. Cette dissociation sera effective à la prise de fonction d’un(e) Directeur/rice général(e) dont le processus de sélection est lancé, Emmanuel Faber se concentrant alors sur les fonctions de Président.Dans l’intervalle, Emmanuel Faber continuera, avec la confiance et le soutien unanime du Conseil, d’exercer les fonctions de Président-Directeur général et de mener la mise en œuvre du plan d’adaptation Local...

KANSAS CITY, Mo., March 01, 2021 (GLOBE NEWSWIRE) — With a perfect 100% score on the Human Rights Campaign’s 2021 Corporate Equality Index, H&R Block (NYSE: HRB) was recognized as one of HRC’s “Best Places to Work for LGBTQ Equality.”H&R Block is one of just eight companies in Kansas City, and 21 in Missouri to receive a 100% score on the Corporate Equality Index, the leading benchmarking survey and report that measures how 1,142 U.S.-based companies are promoting corporate policies and practices related to LGBTQ workplace equality.“At Block, we want to go beyond inclusivity and foster a culture of belonging where associates can bring their whole, authentic selves to work, and where they feel included, inspired, and supported,” said Jeff Jones, president and CEO of H&R Block. “I’m proud of our efforts toward diversity,...

NETANYA, Israel, March 01, 2021 (GLOBE NEWSWIRE) — RADA Electronic Industries Ltd. (Nasdaq: RADA) today announced that it has filed its annual report containing audited consolidated financial statements for the year ended December 31, 2020 with the U.S. Securities and Exchange Commission. The annual report is available on the Company’s website (www.rada.com). Shareholders may receive a hard copy of the annual report free of charge upon request.About RADARADA is a global defense technology company focused on proprietary radar solutions and legacy avionics systems. The company is a leader in mini-tactical radars, serving attractive, high-growth markets, including critical infrastructure protection, border surveillance, active military protection and counter-drone applications. 

NOT FOR RELEASE OR DISTRIBUTION TO U.S. PERSONS OR IN OR INTO THE UNITED STATES OR ITS TERRITORIES OR IN OR INTO ANY OTHER JURISDICTION IN WHICH SUCH RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY LAWGN Store Nord A/S (“GN”) has today successfully signed a private placement issuance in a principal amount of EUR 50 million maturing on March 3, 2036 under its Euro Medium Term Note (EMTN) program.The Notes will be issued on March 3, 2021 with a coupon of 1.970% per annum and will be listed on Euronext Dublin.The net proceeds from the transaction will be used for general corporate purposes.BofA Securities are acting as Manager in connection with the issue.EXCEPT PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), THE NOTES MAY NOT BE OFFERED OR SOLD WITHIN...